Loading…
Edap TMS SA is projected to rise to $5.38 by 2027, a +25% move from its current price of $4.32. EDAP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $4.23 | $4.32 | $4.41 | +0.05% |
| Aug 2 | $4.20 | $4.32 | $4.45 | +0.10% |
| Aug 3 | $4.18 | $4.33 | $4.48 | +0.16% |
| Aug 4 | $4.16 | $4.33 | $4.51 | +0.21% |
| Aug 5 | $4.14 | $4.33 | $4.53 | +0.26% |
| Aug 6 | $4.12 | $4.33 | $4.56 | +0.31% |
| Aug 7 | $4.11 | $4.34 | $4.58 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.11 | $4.34 | $4.58 | +0.36% |
| Week 2 | $4.03 | $4.35 | $4.70 | +0.73% |
| Week 3 | $3.98 | $4.37 | $4.80 | +1.09% |
| Week 4 | $3.93 | $4.38 | $4.88 | +1.46% |
| Week 5 | $3.90 | $4.40 | $4.97 | +1.83% |
| Week 6 | $3.87 | $4.42 | $5.04 | +2.20% |
| Week 7 | $3.84 | $4.43 | $5.11 | +2.57% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
EDAP TMS S.A. is a medical technology company that engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments.
The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. It also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters.
The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales channels, and third-party distributors and agents. The company serves academic, public, and private hospitals, as well as clinics.
It has a strategic collaboration with Telix Pharmaceuticals Limited to develop clinical workflows combining PSMA PET imaging and Focal One Robotic HIFU for prostate cancer. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Vaulx-en-Velin, France.
EDAP TMS SA, symbol EDAP, operates in Healthcare. Its current price is $4.32 and its market capitalization is $161.92M. It ranks 3864 by market cap.
The near-term technical picture shows bullish sentiment, with RSI14 at 70. The price trades around the SMA50 at $4.32, above the SMA200 at $3.48.
Support is at $4.10 and resistance at $5.20, while the 30-day trading range spans $3.77 to $4.94. The stock exhibits notable volatility, with annualized volatility at 40%.
Overall, the price outlook combines a bullish technical setup with a long-run forecast that shows meaningful upside across the coming years.
A major floor 25.5% below — a decisive break under it would weaken the trend.
The nearest floor, 5.1% below — buyers have tended to step in here.
The nearest ceiling, 20.4% above — a clean break opens room to run.
A major ceiling 37.2% above — clearing it would confirm fresh momentum.
Key EDAP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EDAP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.16 | Sell | $5.15 | Sell |
| MA 10 | $5.06 | Sell | $5.06 | Sell |
| MA 20 | $4.88 | Sell | $4.89 | Sell |
| MA 50 | $4.32 | Sell | $4.51 | Sell |
| MA 100 | $4.16 | Buy | $4.14 | Buy |
| MA 200 | $3.48 | Buy | $3.67 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 72.61 | Sell |
| Stoch RSI (14) | 83.42 | Sell |
| CCI (20) | 105.47 | Buy |
| Williams %R (14) | -4.44 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 9.05 | Buy |
| Bollinger %B (20,2) | 0.86 | Neutral |
| Stochastic %K (14) | 95.56 | Sell |
| TRIX (15) | 0.75 | Buy |
| Awesome (5,34) | 0.50 | Buy |
| Ultimate (7,14,28) | 81.10 | Sell |
| Momentum (10) | 0.28 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 5.23 | Sell |
| ADX (14) | 36.33 | Buy |
| ATR (14) | 0.07 | Info |
The 30-day picture is bullish, with RSI14 at 70. Price action sits around the SMA50 of $4.32 while the SMA200 sits at $3.48, indicating a positive near-term trend.
Key levels to watch are support at $4.10 and resistance at $5.20. The 30-day trading range runs from a low of $3.77 to a high of $4.94, highlighting a tight near-term bandwidth.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.22 | $4.32 | $5.85 | 0% | Neutral | |
| $4.38 | $5.38 | $6.93 | +25% | Bullish | |
| $4.82 | $6.04 | $8.00 | +40% | Bullish | |
| $5.10 | $6.49 | $8.79 | +50% | Bullish | |
| $5.58 | $7.22 | $9.97 | +67% | Bullish | |
| $6.22 | $8.15 | $11.44 | +89% | Bullish | |
| $7.48 | $9.92 | $14.15 | +130% | Bullish | |
| $8.50 | $11.41 | $16.49 | +164% | Bullish | |
| $8.84 | $12.00 | $17.56 | +178% | Bullish | |
| $9.22 | $12.64 | $18.72 | +193% | Bullish | |
| $14.40 | $20.67 | $32.18 | +379% | Bullish | |
| $23.53 | $36.53 | $61.22 | +746% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.22 | $4.32 | $5.27 | +0.00% |
| August 2026 | $3.88 | $4.54 | $5.45 | +5.21% |
| September 2026 | $3.84 | $4.53 | $5.48 | -0.35% |
| October 2026 | $3.90 | $4.62 | $5.62 | +1.93% |
| November 2026 | $4.01 | $4.76 | $5.84 | +3.18% |
| December 2026 | $3.98 | $4.75 | $5.85 | -0.25% |
Click any year to see its month-by-month EDAP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The EDAP price prediction for 2026 points to an average of $4.32 (low $3.22, high $5.85) — a potential gain of 0% on today's $4.32. A consolidation phase looks the most probable path here.
In 2027, EDAP is projected to trade between $4.38 and $6.93, averaging $5.38 — a potential gain of +25% from today's $4.32. That is up +25% on the projected 2026 average. Momentum favours further upside here.
Edap TMS SA's 2028 outlook centres on $6.04, within a $4.82 to $8.00 range. That is up +12% on the projected 2027 average. That marks a +40% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, EDAP could reach as high as $8.79, with a base case around $6.49 and support toward $5.10 — roughly +50% from $4.32. Momentum favours further upside here.
Expect EDAP to range from $5.58 to $9.97 through 2030. The $7.22 average target implies a +67% move from current prices. That is up +11% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The EDAP price prediction for 2031 points to an average of $8.15 (low $6.22, high $11.44) — a potential gain of +89% on today's $4.32. Momentum favours further upside here.
In 2032, EDAP is projected to trade between $7.48 and $14.15, averaging $9.92 — a potential gain of +130% from today's $4.32. That is up +22% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Edap TMS SA's 2033 outlook centres on $11.41, within a $8.50 to $16.49 range. That is up +15% on the projected 2032 average. That marks a +164% change versus current levels. Momentum favours further upside here.
By 2034, EDAP could reach as high as $17.56, with a base case around $12.00 and support toward $8.84 — roughly +178% from $4.32. Buyers look set to stay in control over this stretch.
Expect EDAP to range from $9.22 to $18.72 through 2035. The $12.64 average target implies a +193% move from current prices. That is up +5% on the projected 2034 average. Momentum favours further upside here.
The EDAP price prediction for 2040 points to an average of $20.67 (low $14.40, high $32.18) — a potential gain of +379% on today's $4.32. Buyers look set to stay in control over this stretch.
In 2050, EDAP is projected to trade between $23.53 and $61.22, averaging $36.53 — a potential gain of +746% from today's $4.32. That is up +77% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in EDAP today (≈ 231.481481 EDAP) could be worth
$8,455.43
+$7,455.43 (+746%) by 2050 · US Dollar
Based on the average projected EDAP price of $36.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EDAPwould be worth at today's price.
$1,000 invested in EDAP on Jul 2, 2025 (≈ 636.942654 EDAP) would be worth
$2,751.59
+$1,751.59 (+175.2%) today · 2.75× · US Dollar
Based on a EDAP entry price of $1.57 vs. today's $4.32.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.05 | $855.45 | -14.5% |
| 1 month ago | $4.76 | $908.52 | -9.1% |
| 3 months ago | $3.39 | $1,274.34 | +27.4% |
| 6 months ago | $3.4 | $1,270.59 | +27.1% |
| 1 year ago | $1.57 | $2,751.59 | +175.2% |
| All time (4.9y) ago | $6.27 | $689 | -31.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EDAP forecast.
Our base-case forecast reaches $8.60 around 2032.
Implied market cap at $8.60: $322.35M
The multi-year forecast shows a bullish trajectory across the horizon. In 2026, the min price is $3.22, the avg is $4.32, and the max is $5.85, with a 0% ROI and neutral sentiment.
From 2027 onward, the averages rise with 2027 at $5.38, 2028 at $6.04, 2029 at $6.49, and 2030 at $7.22. Corresponding ROIs are 24.6%, 39.9%, 50.3%, and 67.1%, with bullish sentiment prevailing. The path continues higher through 2031 ($8.15 avg), 2032 ($9.92 avg), 2033 ($11.41 avg), 2034 ($12.00 avg), and 2035 ($12.64 avg), with ROIs climbing to 88.6%, 129.7%, 164.1%, 177.7%, and 192.6% respectively.
By 2040, the forecast shows an avg of $20.67 and a max of $32.18 with a 378.6% ROI, followed by 2050 with an avg of $36.53 and a max of $61.22, yielding a 745.5% ROI. Overall, the longer-term view is bullish, but these are estimates and not guarantees; volatility and market dynamics can alter outcomes.
Tap a question to reveal the answer.
2030 avg $7.22, min $5.58, max $9.97; ROI 67.1%; sentiment BULLISH.
Forecasts show a bullish trajectory with 2027 avg $5.38, 2028 avg $6.04, 2029 avg $6.49, 2030 avg $7.22; ROI 24.6% in 2027, 39.9% in 2028, 50.3% in 2029, 67.1% in 2030, and 745.5% by 2050; 2026 ROI is 0; sentiment shifts to BULLISH.
Yes—the max forecast across years is $61.22 in 2050, which would exceed $50.
Current price $4.32; Market cap $161.92M.
Low $3.77, High $4.94.
Edap TMS SA Community Discussion
0Share your Edap TMS SA price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.